Resilient, Empowered, Active Living: REAL Diabetes Study

Sponsor
University of Southern California (Other)
Overall Status
Completed
CT.gov ID
NCT02214641
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH)
81
1
2
33
2.5

Study Details

Study Description

Brief Summary

This three-year award will pilot-test an innovative intervention, Resilient, Empowered, Active Living with Diabetes (REAL), targeting underserved minority young adults with poorly-controlled diabetes. The individually tailored, community-based intervention merges findings of an in-depth needs assessment, principles of an evidence-based occupational therapy intervention (Lifestyle Redesign®) and evidence-based diabetes self-management strategies. A proof-of-concept study demonstrated that REAL is feasible to implement, acceptable to young adults with type 1 diabetes and type 2 diabetes, and has potential to produce positive changes in diabetes self-care and glycemic control. The study will randomize 80 young adults with diabetes to receive either the six-month REAL intervention or an attention control condition. Blinded data collectors will assess glycemic control, diabetes self-care behaviors and quality of life outcomes, as well as potential intervention mediators, before and after the six-month intervention. It is anticipated that findings from this pilot study will be used to inform a large-scale randomized controlled trial of the REAL intervention.

The study's specific aims and hypotheses are as follows:

Aim 1. Determine the intervention's efficacy for the primary outcomes: glycemic control and diabetes self-care.

Hypothesis: At 6 months (immediately following the intervention), intervention group participants will demonstrate improvements in A1C and diabetes self-care as compared to control group participants.

Aim 2. Conduct exploratory analyses of the intervention's impact on secondary outcomes and potential mediating mechanisms (to inform power estimates for a large-scale RCT).

Hypothesis 1: At 6 months, intervention group participants will demonstrate improvements in secondary outcomes: diabetes-related stress and quality of life, depression, and life satisfaction as compared to control group participants.

Hypothesis 2: At 6 months, intervention group participants will demonstrate improvements in potential mediators of the intervention: habit strength, problem solving, activity participation, self-efficacy and diabetes knowledge as compared to baseline.

Aim 3. Conduct a process evaluation utilizing mixed methods to evaluate and refine intervention delivery (e.g. treatment fidelity, patient satisfaction) and study procedures (e.g. recruitment, retention, testing protocol).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Resilient, Empowered, Active Living with Diabetes
  • Behavioral: Information Control
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
81 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Diabetes Self-Management Lifestyle Intervention for Urban Minority Young Adults
Study Start Date :
Oct 1, 2014
Actual Primary Completion Date :
Jun 1, 2016
Actual Study Completion Date :
Jul 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Lifestyle intervention

Resilient, Empowered, Active Living (REAL) Diabetes

Behavioral: Resilient, Empowered, Active Living with Diabetes
Individualized lifestyle intervention incorporating the following topics: Diabetes knowledge; access to healthcare; communication with healthcare providers; incorporation of diabetes self-care tasks within daily habits and routines; social support; and emotional well-being. Participants receive a total of 10-16 hours of intervention by a licensed occupational therapist with training in diabetes education, motivational interviewing and the REAL Diabetes intervention protocol.

Active Comparator: Information Control

Participants will receive a packet of informational materials about diabetes, and receive periodic follow-up phone calls to match for attention dose.

Behavioral: Information Control
Participants will receive a packet of informational materials about diabetes, and receive periodic follow-up phone calls to match for attention dose. The packet of materials will be delivered in an initial home visit. Follow-up phone calls will occur at approximately two week intervals to inquire whether participants have reviewed specific sections of the intervention materials, and clarify information included in the packet.

Outcome Measures

Primary Outcome Measures

  1. Glycated hemoglobin (HbA1C) [Baseline & 6 months.]

    Measure of average blood glucose concentration over approximately the previous 12 weeks.

Secondary Outcome Measures

  1. Audit of Diabetes-Dependent Quality of Life (ADD-QoL) [Baseline & 6 months.]

    19-item survey measure assessing impact of diabetes on social, physical, and emotional functioning.

  2. Problem Areas in Diabetes (PAID) Scale - Short Form [Baseline & 6 months.]

    5-item survey measure assessing diabetes-related distress and emotional problems.

  3. Patient Health Questionnaire-8 (PHQ-8) [Baseline & 6 months]

    8-item survey measure assessing severity of depressive symptoms (identical to PHQ-9 while omitting self-harm item).

  4. Satisfaction With Life Scale (SWLS) [Baseline & 6 months.]

    5-item survey measure assessing global life satisfaction and subjective well-being.

  5. Summary of Diabetes Self-Care Activities (SDSCA) [Baseline & 6 months]

    14 items assessing diet, physical activity, medication adherence and other self-care behaviors relevant to diabetes.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosed with type 1 or type 2 diabetes mellitus for a minimum of 12 months

  • Most recent A1C ≥8.0%

  • Fluent in English or Spanish

  • Reachable by telephone or text message

  • Willing to participate in study activities

  • Reside in Los Angeles County with no plans to relocate

Exclusion Criteria:
  • Pregnant or planning to become pregnant

  • Cognitive impairment or severe disability limiting life expectancy

  • Participated in lifestyle intervention targeting diabetes within past 12 months

  • Participated in formative research related to intervention development.

Contacts and Locations

Locations

Site City State Country Postal Code
1 USC Los Angeles California United States 90089

Sponsors and Collaborators

  • University of Southern California
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators

  • Principal Investigator: Elizabeth Pyatak, PhD, OTR/L, University of Southern California

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Beth Pyatak, Associate Professor, University of Southern California
ClinicalTrials.gov Identifier:
NCT02214641
Other Study ID Numbers:
  • 1K01DK099202-01A1
  • 1K01DK099202-01A1
First Posted:
Aug 12, 2014
Last Update Posted:
Oct 7, 2019
Last Verified:
Oct 1, 2019

Study Results

No Results Posted as of Oct 7, 2019